This titration schedule helps minimise gastrointestinal side effects
Additionally, GLP-1 reduces the release of glucagon, another hormone produced by the pancreas, which typically signals the liver to release stored glucose
On the website clinicaltrials.gov, which includes records of compassionate use programs, STAT could not find any other instances of Eli Lilly previously offering tirzepatide (now known as Zepbound and Mounjaro) to patients through the pathway
For this reason, many clinicians focus on monitoring response over time rather than assuming one dosing path works for everyone
National Institute of Diabetes and Digestive and Kidney Diseases: Prescription Medications to Treat Overweight and Obesity Obesity Medicine Association: Top Weight Loss Medications Sean Hashmi, MD Medical Reviewer Sean Hashmi, MD, is an experienced nephrologist and obesity medicine specialist based in Southern California